182 related articles for article (PubMed ID: 36035192)
1. An inflammation-related signature could predict the prognosis of patients with kidney renal clear cell carcinoma.
Yu Q; Zhang F; Feng D; Li D; Xia Y; Gan MF
Front Genet; 2022; 13():866696. PubMed ID: 36035192
[No Abstract] [Full Text] [Related]
2. A Novel Gene Signature of Tripartite Motif Family for Predicting the Prognosis in Kidney Renal Clear Cell Carcinoma and Its Association With Immune Cell Infiltration.
Zheng D; Zhang Y; Xia Y; Cheng F
Front Oncol; 2022; 12():840410. PubMed ID: 35371994
[TBL] [Abstract][Full Text] [Related]
3. The clinical significance, immune infiltration, and tumor mutational burden of angiogenesis-associated lncRNAs in kidney renal clear cell carcinoma.
Zhang W; Liu Z; Wang J; Geng B; Hou W; Zhao E; Li X
Front Immunol; 2022; 13():934387. PubMed ID: 35958561
[TBL] [Abstract][Full Text] [Related]
4. Cuproptosis-related gene FDX1 as a prognostic biomarker for kidney renal clear cell carcinoma correlates with immune checkpoints and immune cell infiltration.
Yao Y; Chen H; Lou M; Chen T
Front Genet; 2023; 14():1071694. PubMed ID: 36755576
[No Abstract] [Full Text] [Related]
5. GRAMD1A Is a Biomarker of Kidney Renal Clear Cell Carcinoma and Is Associated with Immune Infiltration in the Tumour Microenvironment.
Liu Y; Fu S; Zhang Z; Wang S; Cheng X; Li Z; Ding Y; Sun T; Ma M
Dis Markers; 2022; 2022():5939021. PubMed ID: 35860689
[TBL] [Abstract][Full Text] [Related]
6. Construction and validation of an autophagy-related long noncoding RNA signature for prognosis prediction in kidney renal clear cell carcinoma patients.
Yu J; Mao W; Xu B; Chen M
Cancer Med; 2021 Apr; 10(7):2359-2369. PubMed ID: 33650306
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a novel anoikis-related gene signature in clear cell renal cell carcinoma.
Wu Q; Sun Y; Qin X; Li M; Huang S; Wang X; Weng G
Front Oncol; 2023; 13():1211103. PubMed ID: 37965453
[TBL] [Abstract][Full Text] [Related]
8. A Novel M7G-Related MicroRNAs Risk Signature Predicts the Prognosis and Tumor Microenvironment of Kidney Renal Clear Cell Carcinoma.
Hong P; Du H; Tong M; Cao Q; Hu D; Ma J; Jin Y; Li Z; Huang W; Tong G
Front Genet; 2022; 13():922358. PubMed ID: 35812727
[No Abstract] [Full Text] [Related]
9. Computational construction of TME-related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma.
Zhou L; Fang H; Guo F; Yin M; Long H; Weng G
J Clin Lab Anal; 2022 Aug; 36(8):e24582. PubMed ID: 35808868
[TBL] [Abstract][Full Text] [Related]
10. Chromatin regulators-related lncRNA signature predicting the prognosis of kidney renal clear cell carcinoma and its relationship with immune microenvironment: A study based on bioinformatics and experimental validation.
Zhang X; Qin X; Yu T; Wang K; Chen Y; Xing Q
Front Genet; 2022; 13():974726. PubMed ID: 36338996
[No Abstract] [Full Text] [Related]
11. Identification of a Novel Myc-Regulated Gene Signature for Patients with Kidney Renal Clear Cell Carcinoma.
Fu S; Liu Y; Zhang Z; Mei M; Chen Q; Wang S; Yang X; Sun T; Ma M; Xie W
J Oncol; 2022; 2022():3487859. PubMed ID: 37342680
[TBL] [Abstract][Full Text] [Related]
12. Identification of an m6A-Related lncRNA Signature for Predicting the Prognosis in Patients With Kidney Renal Clear Cell Carcinoma.
Yu J; Mao W; Sun S; Hu Q; Wang C; Xu Z; Liu R; Chen S; Xu B; Chen M
Front Oncol; 2021; 11():663263. PubMed ID: 34123820
[TBL] [Abstract][Full Text] [Related]
13. Construction and Characterization of n6-Methyladenosine-Related lncRNA Prognostic Signature and Immune Cell Infiltration in Kidney Renal Clear Cell Carcinoma.
Chen Z; Huang Z; Hui J; Chen Z; Zhang H; Jiang Y; Zeng W
J Oncol; 2022; 2022():7495183. PubMed ID: 36213821
[TBL] [Abstract][Full Text] [Related]
14. A polyamine metabolism risk signature for predicting the prognosis and immune therapeutic response of kidney cancer.
Li B; Kong Z; Liu Y; Xu B; Liu X; Li S; Zhang Z
Transl Cancer Res; 2023 Oct; 12(10):2477-2492. PubMed ID: 37969387
[TBL] [Abstract][Full Text] [Related]
15. Novel amino acid metabolism-related gene signature to predict prognosis in clear cell renal cell carcinoma.
Cheng X; Deng W; Zhang Z; Zeng Z; Liu Y; Zhou X; Zhang C; Wang G
Front Genet; 2022; 13():982162. PubMed ID: 36118874
[No Abstract] [Full Text] [Related]
16. The Aging-Related Prognostic Signature Reveals the Landscape of the Tumor Immune Microenvironment in Head and Neck Squamous Cell Carcinoma.
Chen F; Gong X; Xia M; Yu F; Wu J; Yu C; Li J
Front Oncol; 2022; 12():857994. PubMed ID: 35619896
[TBL] [Abstract][Full Text] [Related]
17. A 9-gene prognostic signature for kidney renal clear cell carcinoma overall survival based on co-expression and regression analyses.
Zhu W; Ding M; Chang J; Liao H; Xiao G; Wang Q
Chem Biol Drug Des; 2023 Feb; 101(2):422-437. PubMed ID: 36053927
[TBL] [Abstract][Full Text] [Related]
18. Identification and Validation of a Necroptosis-Related Prognostic Signature for Kidney Renal Clear Cell Carcinoma.
Cai M; Yang Q; He J; Wu H; Li Z; Fang Z; Li J
Stem Cells Int; 2023; 2023():8446765. PubMed ID: 36910333
[TBL] [Abstract][Full Text] [Related]
19. Exploration of the relationships between tumor mutation burden with immune infiltrates in clear cell renal cell carcinoma.
Zhang C; Li Z; Qi F; Hu X; Luo J
Ann Transl Med; 2019 Nov; 7(22):648. PubMed ID: 31930049
[TBL] [Abstract][Full Text] [Related]
20. A Novel Prognostic Signature Associated With the Tumor Microenvironment in Kidney Renal Clear Cell Carcinoma.
Pei D; Xu C; Wang D; Shi X; Zhang Y; Liu Y; Guo J; Liu N; Zhu H
Front Oncol; 2022; 12():912155. PubMed ID: 35860566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
